PRONULIFE®LvUCare-Uric Acid Management and Liver Care Probiotics

Product description

The PRONULIFE®LvUCare probiotic combination has been validated through animal experiments to prevent and treat metabolic syndrome symptoms, including fatty liver and hyperuricemia-induced inflammation. In alcohol-fed mouse models, it reduced triglyceride accumulation, alleviating fatty liver. Rat experiments showed prevention of hyperuricemia and were published in international journals. Two clinical studies revealed its ability to break down uric acid in the digestive tract, protecting the liver and reducing kidney burden. Supported by a Taiwanese invention patent (TW I764598) and multiple patent applications in China and the United States, its effectiveness in promoting metabolism and assisting those with socializing habits has been confirmed through animal and human experiments, contributing to overall health.
→See more: https://lihi.cc/R2Dyu/IIN_LvUcare

Specifications

Categories	Clinical trials; Contract manufacturing; Probiotics
Sales markets	Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Supplied from	Taiwan, China
Product Applications	Food Supplements; Natural Products
Product Certifications	Gluten-free; Halal; Health & Safety (GMP, HAACP and equivalents); Health claims; Natural; Quality assurance; Sustainable; Traceable

More products from Glac biotech Co., Ltd.

Totipro®Postbiotics PE0401 for Digestive Health Application

✅ NEWS
Postbiotic ingredient Totipro® PE0401 won the championship in the "Ingredient: Microbiome Modulation" category at the 2023 NutraIngredients Awards. This marks the first-ever nomination and win for a postbiotic ingredient in this prestigious competition.

✅ Introduction
Totipro®...

More info

Totipro®Postbiotics PE0301 for Oral Care Applications

✅ Market InsightThe most common and easily thought of oral care products are typically mouthwash and toothpaste. But, did you know? These daily essentials often contain fluoride, which, while effective in killing both beneficial and harmful bacteria, can disrupt the balance of oral microbiota. On the other...

More info

Lactobacillus rhamnosus MP108

✅ Here are the key achievements of Lactobacillus rhamnosus MP108:
• EFSA-QPS System Permission • Approved probiotic strain for Chinese food, including infant and children formulas • Recognized as an approved food ingredient in Taiwan • Validated through strict safety assessments: Acut...

More info

Bifidobacterium animalis subsp. Lactis CP-9

✅ NewsIn 2023, CP-9 achieved FINALIST with the NutraIngredients Europe Award 2023 in the Weight Management category.
✅ Introduction
Bifidobacterium animalis subsp. lactis CP-9 boasts a range of health benefits for the human body. Include: • Optimizing the human gut microbiota ...

More info

Lactobacillus rhamnosus F-1

✅ Derived form：
Women urogenital tract (Imtimate area)
✅ Health Solutions： • Women care (Intimate care) • Oral health • Stomach health • Anti-inflammation → See more: https://lihi.cc/rViXI/IIN_F-1

More info